toggle menu
Press room
Products
Investors Relations
Corporate Governance
Science and R&D
About
Products
Animal Health
Nutraceuticals
Bio-repellents
Life Science
Webinars
Investors Relations
Financial Reports
Financial Calendar
Press Releases
Commissioned Research
Company description
Prospectus
Årsstämma 2022
Meetings
Investor structure
Investor Enquiries
Corporate Governance
PDMR
Corporate management
Annual General Meeting
Articles of Association
Nomination Committee
Board of directors
Management
Auditors
Certified Advisor
Science and R&D
Our Science
Scientific Reports
Patents
About
About Axichem
Mission & Vision
Eco-friendly
History
Business model
axichem.se
Press releases
Inbjudan att teckna aktier i aXichem AB
Back
October 14, 2009
Inbjudan att teckna aktier i aXichem AB
Back
Härmed inbjuds allmänheten att teckna aktier i aXichem AB
4,50 SEK aktie
Back
Further reading
September 29, 2022
aXichem tillkännager indikativa positiva data, avseende phenylcapcaisins effekt på elitidrottares prestationer, från en studie genomförd vid University of Pablo Olavide, Spanien
September 29, 2022
aXichem announces indicative positive data from trail, regarding phenylcapcaisin’s effect on sports performance in athletes, carried out at University of Pablo Olavide, Spain
September 01, 2022
aXichem obtains a patent for the use of phenylcapsaicin in the treatment of leaky gut
